Search

everythinglearnresearchcommunity

for

Search:↓

The framework helps predict adverse effects of blood thinners, improving drug selection for atrial fibrillation.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Certain drugs that block specific enzymes can help treat prostate diseases.

Inclisiran is effective at lowering cholesterol.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

Torilin from Torilis japonica can inhibit testosterone 5α-reductase but is less effective than finasteride.

Keratin-based hydrogels with calcium are effective for delivering anti-fibrotic drugs.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Early detection and tailored treatment of lupus nephritis are crucial to prevent kidney damage.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

K_ATP channel gene mutations are linked to heart diseases, but more research is needed to understand the connection and treatment potential.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

Ovulation inhibitors effectively treat menstrual issues and improve fertility but can have side effects.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Luliconazole is more effective than ketoconazole at repairing damaged hair cuticles.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Linagliptin slows down premature aging in certain mice.

MK-5108 is safe and shows potential against tumors, especially alone.

Eclipta alba leaf alkaloids may help treat HIV by inhibiting the virus's activity.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.